What a Near-Perfect AUROC Does Not Show: Random-Panel and Label-Permutation Controls for a Sepsis Blood-Transcriptome Signature
4 affiliations
- 1Department of Applied Computer Science and Mathematical Modelling, Faculty of Mathematics and Computer Science, University of Warmia and Mazury in Olsztyn, Słoneczna 54, 10-710 Olsztyn, Poland
- 2Department of Mathematics, University of Architecture, Civil Engineering and Geodesy (UACEG), 1 Hristo Smirnenski Blvd., 1164 Sofia, Bulgaria
- 3Department of Mathematical Modelling and Numerical Methods, Faculty of Applied Mathematics and Informatics, Technical University of Sofia, 8 “Kliment Ohridski” Blvd., 1000 Sofia, Bulgaria
- 4Faculty of Mathematics and Informatics, Sofia University “St. Kliment Ohridski”, 5 James Bourchier Blvd., 1164 Sofia, Bulgaria
Abstract
Sepsis blood-transcriptome signatures are usually judged against healthy controls. Two questions are rarely separated: whether the classifier exceeds chance, and whether its genes outperform an arbitrary list of equal size. We tested both on public microarray data (discovery GSE65682, n = 359; validation GSE57065, n = 53), using the 9983 of 11,222 genes measurable on both platforms. A 10-gene signature was selected by nested cross-validation and applied to validation without refitting. It separated sepsis from health perfectly (area under the receiver operating characteristic curve, AUROC, 1.000). The pipeline exceeded chance: no label permutation in 1000 matched it (p = 0.001). The genes did not outperform random lists: 12.5% of 2000 random 10-gene panels matched or exceeded the signature, as did 67.6% of panels drawn from the same 300 preselected candidates. Against non-infected intensive care patients, cross-fitted AUROC fell to 0.730 (95% confidence interval 0.642–0.818), unchanged after age and sex matching. At a threshold of 0.5, the cross-fitted model called 70 of these 75 patients septic. Selection was unstable: 200 bootstrap resamples gave a median of 6 genes, from 109 distinct genes. A near-perfect AUROC against healthy controls reflects an easy benchmark, not a specific gene list.
Related
- Transcriptome Analysis Identifies a Myeloid-Like Signature in Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Patients With Poor Response to CD19 Chimeric Antigen Receptor T Cell Therapy.
- Machine learning reveals a multimodal, transdiagnostic signature of emotion dysregulation vulnerability across patients, offspring, and controls
- Senescence-Associated Transcriptome Reversal Prioritizes Repurposing Candidates for Diabetic Kidney Disease: A Computational Study
- Single-cell transcriptome analysis highlights conserved transcriptional responses across multiple models of Retinitis Pigmentosa
- HDAC inhibitor treatment restores transcriptome, chromatin accessibility, and memory deficits in a mouse model for Down syndrome
BibTeX
@article{kolev2026what,
title = {{What a Near-Perfect AUROC Does Not Show: Random-Panel and Label-Permutation Controls for a Sepsis Blood-Transcriptome Signature}},
author = {Mikhail Kolev and Irina Naskinova and Meglena Lazarova and Velin Klisurov and Hristo Kalinov},
journal = {International Journal of Molecular Sciences},
year = {2026},
month = oct,
doi = {10.3390/ijms27209273},
url = {https://www.mdpi.com/1422-0067/27/20/9273},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - What a Near-Perfect AUROC Does Not Show: Random-Panel and Label-Permutation Controls for a Sepsis Blood-Transcriptome Signature
AU - Mikhail Kolev
AU - Irina Naskinova
AU - Meglena Lazarova
AU - Velin Klisurov
AU - Hristo Kalinov
PY - 2026
DA - 2026/10/01
JO - International Journal of Molecular Sciences
DO - 10.3390/ijms27209273
UR - https://www.mdpi.com/1422-0067/27/20/9273
AB - Sepsis blood-transcriptome signatures are usually judged against healthy controls. Two questions are rarely separated: whether the classifier exceeds chance, and whether its genes outperform an arbitrary list of equal size. We tested both on public microarray data (discovery GSE65682, n = 359; validation GSE57065, n = 53), using the 9983 of 11,222 genes measurable on both platforms. A 10-gene signature was selected by nested cross-validation and applied to validation without refitting. It separated sepsis from health perfectly (area under the receiver operating characteristic curve, AUROC, 1.000). The pipeline exceeded chance: no label permutation in 1000 matched it (p = 0.001). The genes did not outperform random lists: 12.5% of 2000 random 10-gene panels matched or exceeded the signature, as did 67.6% of panels drawn from the same 300 preselected candidates. Against non-infected intensive care patients, cross-fitted AUROC fell to 0.730 (95% confidence interval 0.642–0.818), unchanged after age and sex matching. At a threshold of 0.5, the cross-fitted model called 70 of these 75 patients septic. Selection was unstable: 200 bootstrap resamples gave a median of 6 genes, from 109 distinct genes. A near-perfect AUROC against healthy controls reflects an easy benchmark, not a specific gene list.
SN - 1422-0067
ER -